Back
CytomX Therapeutics, Inc. 10K Form
Buy
51
CTMX
CytomX Therapeutics, Inc.
Last Price:
$3.96
Seasonality Move:
11.81%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CTMX News And Ratings
See the #1 stock for the next 7 days that we like better than CTMX
CTMX Financial Statistics
Sales & Book Value
| Annual Sales: | $138.1M |
|---|---|
| Cash Flow: | $-15.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.65 |
| Price / Book: | 6.23 |
Profitability
| EPS (TTM): | 0.41820 |
|---|---|
| Net Income (TTM): | $28M |
| Gross Margin: | $136.3M |
| Return on Equity: | 61.33% |
| Return on Assets: | 20.2% |
CytomX Therapeutics, Inc. Earnings Forecast
Key CytomX Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 5 years for CTMX is 98.72%.
-
The Selling, General & Administrative Expenses for CTMX have been equal to 21.52% of Gross Profit Margin.
-
The Research & Development expenses have been 59.20% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of CTMX is 23.08% of Total Revenues.
-
Per Share Earnings over the last 12 years have been positive in 6 years.
CytomX Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CTMX |
| CUSIP: | 23284F |
| Website: | cytomx.com |
Debt
| Debt-to-Equity Ratio: | 0.05 |
|---|---|
| Current Ratio: | 3.64 |
| Quick Ratio: | 3.54 |
Price-to-Earnings
| Trailing P/E Ratio: | 10.5 |
|---|---|
| Forward P/E Ratio: | 0 |
CTMX Technical Analysis vs Fundamental Analysis
Buy
51
CytomX Therapeutics, Inc. (CTMX)
is a Buy
Is CytomX Therapeutics, Inc. a Buy or a Sell?
-
CytomX Therapeutics, Inc. stock is rated a BuyThe current CytomX Therapeutics, Inc. [CTMX] share price is $3.95. The Score for CTMX is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.